Geode Capital Management’s Benitec Biopharma BNTC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.86M | Buy |
415,211
+181,391
| +78% | +$2.12M | ﹤0.01% | 2748 |
|
|
2025
Q1 | $3.04M | Buy |
233,820
+36,724
| +19% | +$478K | ﹤0.01% | 2881 |
|
|
2024
Q4 | $2.49M | Buy |
197,096
+113,109
| +135% | +$1.43M | ﹤0.01% | 3053 |
|
|
2024
Q3 | $772K | Buy |
83,987
+20,012
| +31% | +$184K | ﹤0.01% | 3445 |
|
|
2024
Q2 | $447K | Buy |
63,975
+53,951
| +538% | +$377K | ﹤0.01% | 3601 |
|
|
2024
Q1 | $51.3K | Hold |
10,024
| – | – | ﹤0.01% | 4315 |
|
|
2023
Q4 | $32.5K | Hold |
10,024
| – | – | ﹤0.01% | 4442 |
|
|
2023
Q3 | $30.3K | Sell |
10,024
-38,199
| -79% | -$115K | ﹤0.01% | 4535 |
|
|
2023
Q2 | $11.5K | Hold |
48,223
| – | – | ﹤0.01% | 4708 |
|
|
2023
Q1 | $10.1K | Sell |
48,223
-1,246
| -3% | -$262 | ﹤0.01% | 4764 |
|
|
2022
Q4 | $8K | Sell |
49,469
-11,498
| -19% | -$1.86K | ﹤0.01% | 4857 |
|
|
2022
Q3 | $22K | Buy |
60,967
+486
| +0.8% | +$175 | ﹤0.01% | 4903 |
|
|
2022
Q2 | $70K | Buy |
60,481
+915
| +2% | +$1.06K | ﹤0.01% | 4694 |
|
|
2022
Q1 | $139K | Buy |
59,566
+1,153
| +2% | +$2.69K | ﹤0.01% | 4534 |
|
|
2021
Q4 | $153K | Buy |
58,413
+4,721
| +9% | +$12.4K | ﹤0.01% | 4591 |
|
|
2021
Q3 | $191K | Buy |
53,692
+19,199
| +56% | +$68.3K | ﹤0.01% | 4468 |
|
|
2021
Q2 | $146K | Buy |
34,493
+5,933
| +21% | +$25.1K | ﹤0.01% | 4452 |
|
|
2021
Q1 | $147K | Buy |
+28,560
| New | +$147K | ﹤0.01% | 4208 |
|